US Therapeutic Plasma Exchange Market

US Therapeutic Plasma Exchange Market - New report by MarketsandMarkets™

The overall market of US therapeutic plasma exchange is estimated to reach $260.0 million by 2021, growing at a CAGR of 11% to 12% during the forecast period (2016 to 2021). Factors such as the growing prevalence of neurological diseases; increasing clinical response rate for therapeutic plasma exchange in Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy, and myasthenia gravis; and growing prevalence of multiple sclerosis in the US are driving the growth of the US therapeutic plasma exchange market. However, factors such as high cost of therapeutic plasma exchange procedures, lack of awareness about the TPE process, dearth of skilled professionals, and risks associated with therapeutic plasma exchange procedure are restraining the growth of the overall market to a certain extent.

Haemonetics Corporation (U.S.), Fresenius Medical Care (Germany), and Terumo BCT, Inc. (U.S.) are the leading players in this consolidated market. The leading position of Haemonetics Corporation is attributed to its wide product portfolio in both TPE devices and disposables segments. Moreover, the company has a wide geographic presence across the U.S., Europe, and Asia, which enables it to cater to customers across the globe. Around 50% of the company’s revenue is generated from the U.S. market. The company mainly focuses on acquisitions and partnerships & collaborations to maintain its leadership position in the market.

To know about the assumptions considered for the study download the pdf brochure

Fresenius Medical Care is another leading company in the U.S. therapeutic plasma exchange market. This is attributed to the company’s strong presence across North America, Europe, Asia-Pacific, Latin America, and Africa. The company is also expanding its presence in the emerging markets. In order to increase its market share and revenue, the company pursues the strategy of mergers and acquisitions.

In the past three years, a majority of the top players adopted agreements, collaborations, and partnerships; geographic expansions; mergers and acquisitions; and new product launches as their key growth strategies. Agreements, collaborations, and partnerships was the majorly adopted strategy by key players in the U.S. therapeutic plasma exchange market. For instance, in May 2014, Terumo BCT collaborated with Kaneka Corporation (Japan), a life sciences company, for gaining market authorization for its Terumo BCT Spectra Optia Apheresis System with Kaneka’s Liposorber LA-40S LDL Adsorption Column in the U.S.

Related Reports:

US Therapeutic Plasma Exchange Market Size & Share by Procedures & Patients (Guillain Barre Syndrome, Multiple Sclerosis, Myasthenia Gravis, Thrombotic Thrombocytopenic Purpura, Glomerulonephritis), Indication (Neurological & Autoimmune Disorders) - Forecasts to 2021

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

Report Code
MD 4451
Published ON
Jul, 2016
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the US Therapeutic Plasma Exchange Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved